- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
- Practice your dividend trading strategies and win cash in our stock game.
- You can view the full Johnson & Johnson Ratings Report.
The $101 billion market cap pharma could be put in play or targeted by an activist investor soon.
We toured the company designing cool workspaces for Fortune 500 companies like Facebook and Microsoft.
Shares of Johnson & Johnson are poised for a rally as the stock is currently trading about 8% off its 52-week high.